PRESS RELEASE:  FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex
Learn More

  1. Home
  2. Home

Home

About Us

Girl Smiling

GW is the global leader in developing cannabinoid-based medicines.

READ MORE >

Healthcare Professionals

Boy and Mother Looking at Something

GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics.

READ MORE >

Patients & Caregivers

Girl Blowing Bubbles

"GW's vision is to be the global leader in prescription cannabinoid medicines, developing and commercializing pharmaceutical products which address clear unmet needs." >


-Justin Gover,
Chief Executive Officer

Investors & Media

Arlo and his mother

Click here to view Investors Relations section. >

Careers

Boy Looking at Something

Join GW Pharmaceuticals where you can positively impact the lives of patients. >

Recent News

Girl Blowing Bubbles
Sep 10, 2020
Greenwich Biosciences to Present Data on Safety and Efficacy of Nabiximols in Persons with Multiple Sclerosis-Associated Spasticity at the Joint ACTRIMS-ECTRIMS Meeting, MSVirtual2020
Read More >

Contact Us